1-3 of 3
Albert D. Donnenberg, Ph.D.
Close
Sort by
Journal Articles

Outpatient High-Dose Chemotherapy and Autologous Hematopoietic Cell Transplantation for Multiple Myeloma Is Associated with a Low Infection Safety Profile.

Mounzer E. Agha, M.D., Andrew M. Yeager, M.D., Carol Evans, M.D., Nikol Borkowski, P.A.-C., Anne Marie Scekeres, R.N., Sarah Miller, P.A.-C., Cheryl Tompkins, C.R.N.P., Rowena Schwartz, Pharm.D., Albert D. Donnenberg, Ph.D., Jeffrey Shogan, M.D.
Journal: Blood
Blood (2004) 104 (11): 5070.
https://doi.org/10.1182/blood.V104.11.5070.5070
Published: 2004
Journal Articles

Infection Is the Major Cause of Mortality after Nonmyeloablative Unrelated Bone Marrow Transplantation with Alemtuzumab, Fludarabine and Melphalan.

Michael P. Carroll, M.D., Diane BuchBarker, M.D., Rowena Schwartz, Pharm.D., Mounzer E. Agha, M.D., Cheryl Tompkins, C.R.N.P., Kristen Baileys, C.R.N.P., Kathleen O’Connell, R.N., Albert D. Donnenberg, Ph.D., Andrew M. Yeager, M.D.
Journal: Blood
Blood (2004) 104 (11): 5165.
https://doi.org/10.1182/blood.V104.11.5165.5165
Published: 2004
Journal Articles

Intensive Immunosuppression Plus T-Cell Depleted Autologous Peripheral Blood Stem Cell Transplantation for Systemic Sclerosis.

Diane BuchBarker, M.D., Albert D. Donnenberg, Ph.D., Thomas A. Medsger, M.D., Michael P. Carroll, M.D., Deborah L. Griffin, B.A., Carol Blair, R.N., Darrell Lis, R.N., M.S.N., Andrew M. Yeager, M.D.
Journal: Blood
Blood (2004) 104 (11): 5205.
https://doi.org/10.1182/blood.V104.11.5205.5205
Published: 2004